- Wednesday, December 10, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global Injection Pen Market- By Type (Disposable and Reusable Pens), By Therapy (Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility), End User (Homecare and Hospitals), and By Region (North America, Europe, Asia Pacific, South America, and Middle East, & Africa)- Global forecast from 2022-2030.
Global Injection Pen Market Overview
The global Injection Pen market is estimated to reach USD 72.3 billion by 2030, growing at a CAGR of 6.5% during the forecast period of 2022-2030. It was valued at USD 46.4 billion in 2022. The Injection pen is very convenient for diabetic patients to carry and use, and avoids the risk of accidentally breaking the syringe when using a glass syringe to inject insulin. Anti-diabetic drugs such as insulin usually given by injection called diabetes injection pens. The amount of insulin used for accurate transmission is less painful and intrusive in the process of the diabetes injection pen market. It is very beneficial for patients who are old or visually impaired.Global Injection Pen Market Insights
The increased global prevalence of diabetes expected to drive the injection pen market for diabetic patients during the forecast period. Additionally, some problems, like the amount of insulin and improper difficulties faced by elderly patients, can overcome by diabetes injection pens. There are various advantages of using injection pens, such as self-injection operation, which is simple, convenient, and safe. It reduces the waste of medicine, and the dose is adjustable. It automatically returns to zero after the injection completed by setting the return sound. Also, with other benefits such as the scale window increases, Injection resistance is reduced, reduction in pain, improved user experience. Moreover, the use of an injection pen not only enhances the patient’s dependence, reduces the economic burden, but also alleviates the social pressure of fewer doctors and more patients. Moreover, government support in the injection pen market has boomed its market share in the global market. Additionally, the rapid development of technology in healthcare products coupled with rising chronic diseases such as diabetics, osteoporosis, growth hormone deficiency, and arthritis has increased the awareness among people regarding the use of an injection pen. Therefore, the prevalence of chronic diseases is capturing the market demand for the global injection pen market. Furthermore, the rising geriatric population and an aging population are expanding the healthcare business and increasing the market of the injection pen. The treatment of injection pen is flexible, cost-effective, reduces the pain and cost for visiting the doctors have enhanced the adoption of injection pen in the global market.Growth Driver
Technology advancement
Traditional methods of injection drugs such as vials and syringes replace with an injection pen, which is way more convenient than earlier. Various diseases such as rheumatoid arthritis, multiple sclerosis treatment drugs, and osteoporosis treatment drugs (such as salmon calcitonin, etc.), can be treated with injection pen at homes. Thus, it reduces the hospital’s expenses, saves time, and they are flexible to use. Therefore, technology development has improved healthcare facilities.Flexibility
The flexibility of the injection pen has increased its adoption in the market, owing to the rising old age population, obesity, and other chronic diseases that have fueled the demand for the injection pen. The injection pen allows the patient to do their treatment themselves and also improves the quality of life of the patient as injection pens are disposable and reusable as well.By Type Segmental Analysis
Based on the Type, the global Injection Pen market bifurcated into Disposable and Reusable Pens. The disposable injection pen segment has captured the largest share in the global injection pen market. The disposable injection pens are more convenient than reusable pens owing to fewer chances of infection, cost-effective, and flexible to use characteristics that are deriving the global injection market. Additionally, the disposable injection pen with pre-filled medicine does not require the patient to switch the drug between the vial and the syringe during self-injection. The desired dose can be directly set and injected through the dose setting part, thus can make the patient out of danger faster than traditional disposable syringes and powder injection medicines. Therefore, it can help ordinary patients to master the operation steps faster and further improve the self-management of patients in the field of chronic diseases.By Therapy Segmental Analysis
Based on the therapy, the global Injection Pen market classified into Diabetes (Insulin, Glucagon-Like Peptide-1), Growth Hormone Therapy, Osteoporosis, Fertility. The diabetes segment held the largest market share in the global injection pen market. Insulin is the only hormone in the body that can lower blood sugar. That is why many people get diabetes is mostly related to the damage of insulin in the body. Therefore, insulin needed for the treatment of diabetes. Diabetic people use an injection pen owing to its advantages such as it is easy to carry, has simple operation, and a pen is simple to operate. The dosage of insulin is precisely adjusted. Therefore, the market demand for injection pens is fueling due to the rising number of diabetic patients worldwide.By End-uses Segmental Analysis
Based on the End-uses, the global Injection Pen market aggregated into Homecare and Hospitals. The home care segment captures largest market share of injection pens. It is mainly due to the rising awareness of injection pens through various programs initiated by the government. Also, the emerging prevalence of diabetes, other diseases, and therapies are fueling injection pen market demand. In addition to it, the features of the injection pen have increased its adoption in the global injection pens market.By Region Segmental Analysis
Based on geography, the global Injection Pen market segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America will be expecting to witness the highest growth during the forecast period from 2022-2030. North America holds largest market share of injection pens in the global market. The rising disposable income, advancement in technology, people’s awareness regarding diabetic products, and emerging geriatric population is fueling the market share of the injection pens.Competitor Analysis
Companies such as Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd among others are key players in the global Injection Pen market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global Injection Pen manufacturing companies
- Research organizations and consulting companies’ Injection Pen
- Regulatory bodies
Scope of the report
| Report Attribute | Details |
|---|---|
| Market size value in 2020 | USD 38.1 billion |
| Revenue forecast in 2027 | USD 54.3 billion |
| Growth Rate | CAGR of 6.25% from 2020 to 2027 |
| Historical data | 2017-2019 |
| Forecast period | 2021 – 2027 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | Merck KGaA,Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Thermo Fisher Scientific Inc., Danaher Corporation, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd. |
Recent Developments
- In September 2021, Merck KGaA and Biocorp SA collaborated to develop a Mallya smart device to monitor human growth hormone (HGH) treatment.
- In April 2021, Novo Nordisk announced the availability of Ozempic Injection for monthly maintenance therapy as a single pen consisting of four 1mg doses.
- In April 2021, Schreiner MediPharm announced the development of an NFC label for Ypsomed’s UnoPen combined with the SmartPilot add-on, which helps patients use the device properly and follow medical plans.
The objective of the Research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves steps such as examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps in assessing potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines in-depth scenario of the target market by the process of grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs wants, and cultural characteristics that can be specifically targeted.
Market Modelling
By Type- Disposable injection pens
- Reusable injection pen
- Diabetes
- Insulin
- GLP-1
- Growth hormone therapy
- Fertility
- Osteoporosis
- Other therapies
- Hospitals
- Home care
- Europe
- North America
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Employee Monitoring Software Market
Report Content
- Research Strategic Development
1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation
- Research Methodology
2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation
- Executive Summary
- Market Insights
4.1. Supply Chain Analysis
4.2. Economic Factor Analysis
4.2.1. Drivers
4.2.2. Trends
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Landscape
4.4. Competitors & Product Analysis
4.5. Regulatory Framework
4.6. Company market share analysis, 2022
4.7. Porter’s Five forces analysis
4.8. Price point analysis
4.9. New Investment Analysis
4.10. PESTEL Analysis
- Global Injection Pen Market Overview
5.1. Market Size & Forecast,2017-2030
5.1.1. Demand
5.1.1.1. By Value (USD Billion)
5.2. Market Share & Forecast, 2017-2030
5.2.1. By Type
5.2.1.1. Disposable injection pens
5.2.1.2. Reusable injection pen
5.2.2. By Therapy
5.2.2.1. Diabetes
5.2.2.1.1. Insulin
5.2.2.1.2. GLP-1
5.2.2.2. Growth hormone therapy
5.2.2.3. Fertility
5.2.2.4. Osteoporosis
5.2.2.5. Other therapies
5.2.3. By End-User
5.2.3.1. Hospitals
5.2.3.2. Homecare
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific
5.2.4.4. South America
5.2.4.5. The Middle East & Africa
- North America Injection Pen Market Overview
6.1. North America Injection Pen Market Size & Forecast,2017-2030
6.1.1. Demand
6.1.1.1. By Value (USD Billion)
6.2. Market Share & Forecast, 2017-2030
6.2.1. By Type
6.2.1.1. Disposable injection pens
6.2.1.2. Reusable injection pen
6.2.2. By Therapy
6.2.2.1. Diabetes
6.2.2.1.1. Insulin
6.2.2.1.2. GLP-1
6.2.2.2. Growth hormone therapy
6.2.2.3. Fertility
6.2.2.4. Osteoporosis
6.2.2.5. Other therapies
6.2.3. By End-User
6.2.3.1. Hospitals
6.2.3.2. Homecare
6.2.4. By Country
6.2.4.1. US
6.2.4.2. Canada
6.2.4.3. Mexico
6.2.5. Company Market Share (Top 3-5)
6.2.6. Economic Impact Study on North America Injection Pen Market
- Europe Injection Pen Market Overview
7.1. Europe Injection Pen Market Size & Forecast,2017-2030
7.1.1. Demand
7.1.1.1. By Value (USD Billion)
7.2. Market Share & Forecast, 2017-2030
7.2.1. By Type
7.2.1.1. Disposable injection pens
7.2.1.2. Reusable injection pen
7.2.2. By Therapy
7.2.2.1. Diabetes
7.2.2.1.1. Insulin
7.2.2.1.2. GLP-1
7.2.2.2. Growth hormone therapy
7.2.2.3. Fertility
7.2.2.4. Osteoporosis
7.2.2.5. Other therapies
7.2.3. By End-User
7.2.3.1. Hospitals
7.2.3.2. Homecare
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. UK
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Rest of Europe
7.2.5. Company Market Share (Top 3-5)
7.2.6. Economic Impact Study on Europe Injection Pen Market
- Asia-Pacific Injection Pen Market Overview
8.1. Asia-Pacific Injection Pen Market Size & Forecast,2017-2030
8.1.1. Demand
8.1.1.1. By Value (USD Billion)
8.2. Market Share & Forecast, 2017-2030
8.2.1. By Type
8.2.1.1. Disposable injection pens
8.2.1.2. Reusable injection pen
8.2.2. By Therapy
8.2.2.1. Diabetes
8.2.2.1.1. Insulin
8.2.2.1.2. GLP-1
8.2.2.2. Growth hormone therapy
8.2.2.3. Fertility
8.2.2.4. Osteoporosis
8.2.2.5. Other therapies
8.2.3. By End-User
8.2.3.1. Hospitals
8.2.3.2. Homecare
8.2.4. By Country
8.2.4.1. India
8.2.4.2. Japan
8.2.4.3. Australia
8.2.4.4. Rest of Asia Pacific
8.2.5. Company Market Share (Top 3-5)
8.2.6. Economic Impact Study on Asia Pacific Injection Pen Market
- South America Injection Pen Market Overview
9.1. South America Injection Pen Market Size & Forecast,2017-2030
9.1.1. Demand
9.1.1.1. By Value (USD Billion)
9.2. Market Share & Forecast, 2017-2030
9.2.1. By Type
9.2.1.1. Disposable injection pens
9.2.1.2. Reusable injection pen
9.2.2. By Therapy
9.2.2.1. Diabetes
9.2.2.1.1. Insulin
9.2.2.1.2. GLP-1
9.2.2.2. Growth hormone therapy
9.2.2.3. Fertility
9.2.2.4. Osteoporosis
9.2.2.5. Other therapies
9.2.3. By End-User
9.2.3.1. Hospitals
9.2.3.2. Homecare
9.2.4. By Country
9.2.4.1. Brazil
9.2.4.2. Argentina
9.2.4.3. Rest of South America
9.2.5. Company Market Share (Top 3-5)
9.2.6. Economic Impact Study on South America Injection Pen Market
- The Middle East & Africa Injection Pen Market Overview
10.1. The Middle East & Africa Injection Pen Market Size & Forecast,2017-2030
10.1.1. Demand
10.1.1.1. By Value (USD Billion)
10.2. Market Share & Forecast, 2017-2030
10.2.1. By Type
10.2.1.1. Disposable injection pens
10.2.1.2. Reusable injection pen
10.2.2. By Therapy
10.2.2.1. Diabetes
10.2.2.1.1. Insulin
10.2.2.1.2. GLP-1
10.2.2.2. Growth hormone therapy
10.2.2.3. Fertility
10.2.2.4. Osteoporosis
10.2.2.5. Other therapies
10.2.3. By End-User
10.2.3.1. Hospitals
10.2.3.2. Homecare
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Rest of the Middle East & Africa
10.2.5. Company Market Share (Top 3-5)
10.2.6. Economic Impact Study on Middle East & Africa Injection Pen Market
- Competitor Analysis
11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Novo Nordisk
11.7.2. Eli Lilly
11.7.3. Sanofi
11.7.4. Merck
11.7.5. Ypsomed
11.7.6. AstraZeneca
11.7.7. Hoffman-La Roche
11.7.8. Becton Dickinson and Company
11.7.9. Owen Mumford
11.7.10. Novartis
11.7.11. Pfizer
11.7.12. Haselmeier
11.7.13. Other Prominent Players
Frequently Asked Questions (FAQ):
The global Injection Pen market is estimated to reach USD 72.3 billion by 2030, and It was valued at USD 46.4 billion in 2022.
The Injection Pen market will grow at a compound annual growth rate of 6.5% from 2022 to 2030.
Homecare and Hospitals are the end-users of the Injection Pen market products.
The growing spread of chronic diseases, technological advancement, an increasing number of regulatory approvals are the growth drivers of the Injection Pen market.
Merck KGaA,Eppendorf AG, Sartorius AG, GEA Group Aktiengesellschaft, bbi-biotech GmbH, Thermo Fisher Scientific Inc., Danaher Corporation, Esco Group of Companies, Pierre Guérin, Solaris Biotechnology Srl., PBS Biotech, Inc., ZETA GmbH, Applikon Biotechnology BV, Meissner Filtration Products, Inc., and Shanghai Bailun Biotechnology Co. Ltd are the key players of the Injection Pen market.
